Literature DB >> 9316622

Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.

H Suzuki1, S Abo, M Kitamura, M Hashimoto, K Izumi, K Terada, T Sugiyama.   

Abstract

Gene amplification is a relatively frequent event in human malignant tumors and is believed to play an important role in tumor progression. The int-2 and erbB genes are amplified more frequently than any other genes in human esophageal cancer. In order to investigate the correlation between these two proto-oncogenes and the clinical behavior of esophageal cancer, we examined DNA amplification of int-2 and erbB and analyzed their relationship to clinicopathological variables. Genomic DNA was extracted from 21 esophageal squamous carcinomas and normal esophageal mucosa, as well as from 4 metastatic tumors. We used Southern blot analysis for detection of gene amplification. Amplification of int-2 was observed in 13 of 21 cases (62%) and in all the metastatic tumors (4/4; 100%). We found a significant correlation between amplification of int-2 and the length of the primary lesion. Amplification of erbB was detected in 3 of 18 patients (17%). All patients who showed amplification of erbB also demonstrated amplification of int-2. These results suggest that amplification of int-2 or neighboring genes on 11q may participate in tumor progression and metastasis in patients with esophageal squamous cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316622     DOI: 10.3109/07357909709047579

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  5 in total

1.  Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinoma.

Authors:  Yong Chen; Shuang-Mei Zhu; Xiao-Ling Xu; A N Zhao; Jin-Lin Hu
Journal:  Oncol Lett       Date:  2015-11-25       Impact factor: 2.967

2.  Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.

Authors:  Na Zhan; Wei-Guo Dong; Yong-Fei Tang; Ze-Sheng Wang; Cheng-Long Xiong
Journal:  Med Oncol       Date:  2011-02-13       Impact factor: 3.064

3.  Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.

Authors:  Patrapim Sunpaweravong; Somkiat Sunpaweravong; Puttisak Puttawibul; Winyou Mitarnun; Chan Zeng; Anna E Barón; Wilbur Franklin; Sherif Said; Marileila Varella-Garcia
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-19       Impact factor: 4.553

4.  FAM175B promotes apoptosis by inhibiting ATF4 ubiquitination in esophageal squamous cell carcinoma.

Authors:  Yu Zhao; Yang Yu; Hengcun Li; Zheng Zhang; Shuilong Guo; Shengtao Zhu; Qingdong Guo; Peng Li; Li Min; Shutian Zhang
Journal:  Mol Oncol       Date:  2019-03-23       Impact factor: 6.603

Review 5.  A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.

Authors:  J M Findlay; M R Middleton; I Tomlinson
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.